ResMed (RMD)
(Delayed Data from NYSE)
$180.35 USD
+1.50 (0.84%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $180.38 +0.03 (0.02%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC4/25/24 |
---|---|
Current Quarter | 1.92 |
EPS Last Quarter | 1.88 |
Last EPS Surprise | 3.87% |
ABR | 1.68 |
Earnings ESP
|
-2.35% |
---|---|
Current Year | 7.47 |
Next Year | 8.27 |
EPS (TTM) | 6.80 |
P/E (F1) | 23.96 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.18B | 1.21B | 4.65B | 4.95B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 1.20B | 1.24B | 4.70B | 5.00B |
Low Estimate | 1.17B | 1.18B | 4.62B | 4.90B |
Year ago Sales | 1.12B | 1.12B | 4.22B | 4.65B |
Year over Year Growth Est. | 5.52% | 7.66% | 10.06% | 6.59% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.92 | 1.94 | 7.47 | 8.27 |
# of Estimates | 4 | 5 | 6 | 6 |
Most Recent Consensus | 1.87 | 1.92 | 7.29 | 8.04 |
High Estimate | 1.98 | 2.09 | 7.70 | 8.96 |
Low Estimate | 1.87 | 1.81 | 7.29 | 7.72 |
Year ago EPS | 1.68 | 1.60 | 6.44 | 7.47 |
Year over Year Growth Est. | 14.29% | 21.25% | 15.99% | 10.82% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 1 | 0 | 3 | 3 |
Up Last 60 Days | 1 | 0 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | 1.92 | 1.94 | 7.47 | 8.27 |
7 Days Ago | 1.92 | 1.94 | 7.46 | 8.24 |
30 Days Ago | 1.91 | 1.94 | 7.45 | 8.18 |
60 Days Ago | 1.91 | 1.94 | 7.45 | 8.18 |
90 Days Ago | 1.90 | 1.92 | 7.47 | 8.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.87 | 1.94 | 7.48 | 8.42 |
Zacks Consensus Estimate | 1.92 | 1.94 | 7.47 | 8.27 |
Earnings ESP | -2.35% | 0.00% | 0.25% | 1.77% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.88 | 1.64 | 1.60 | 1.68 | NA |
Estimate | 1.81 | 1.63 | 1.67 | 1.57 | NA |
Difference | 0.07 | 0.01 | -0.07 | 0.11 | 0.03 |
Surprise | 3.87% | 0.61% | -4.19% | 7.01% | 1.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more